Cetrorelix Acetate
GnRH antagonist for IVF applications. Flexible administration schedule with immediate LH suppression, enabling personalized ovarian stimulation protocols in assisted reproduction.
Cetrorelix acetate is a synthetic decapeptide and a potent GnRH (Gonadotropin-Releasing Hormone) receptor antagonist. It competitively blocks GnRH receptors on the pituitary gonadotroph cells, rapidly suppressing the secretion of luteinizing hormone (LH) and follicle-stimulating hormone (FSH) without the initial flare-up effect characteristic of GnRH agonists. This makes it particularly valuable in assisted reproductive technology (ART) protocols.
| Parameter | Specification |
| CAS | 120287-85-6 |
| Molecular Formula | C₇₀H₉₂ClN₁₇O₁₄ |
| Molecular Weight | 1431.06 g/mol |
| Category | GnRH/Reproductive |
| Purity | ≥99% |
| Status | GMP-compliant, FDA-ready |
| Applications | IVF, ovarian stimulation, fertility treatment, LH surge prevention |
| CAS | 120287-85-6 |
|---|---|
| Applications | Assisted Reproduction, Controlled Ovarian Hyperstimulation, Fertility Treatment |
Related products
-
Liraglutide
CAS: 204656-20-2Applications: cardiovascular risk reduction, GLP-1, obesity management -
Ganirelix
CAS: 123246-29-7 -
Lixisenatide
CAS: 320367-13-3Applications: postprandial glucose control, Short-acting GLP-1, Type 2 diabetes -
